The research groups led by Wolfgang Kastenmüller and Georg Gasteiger employed innovative microscopy techniques to observe how ...

Pembrolizumab shows clinical promise as a treatment for mycosis fungoides and Sézary syndrome, achieving a response in nearly ...

Q4 2024 Earnings Call Transcript March 27, 2025 Innate Pharma S.A. misses on earnings expectations. Reported EPS is $-0.33474 EPS, expectations were $-0.26681. Operator: Hello, and welcome to the ...

FDA Breakthrough Therapy Designation granted to lacutamab for relapsed or refractory Sézary syndrome New data, including lacutamab improved health-related quality of life data from TELLOMAK ...

The two main types are B lymphocytes (B cells) and T lymphocytes (T cells). B cells and T cells have different functions. Lymphomas are cancers of B and T cells. Cancers of the B cells act differently ...

It’s more common in older adults, people with weakened immune systems, and people with primary CNS lymphoma. There are two main types of lymphocytes, called B cells and T cells. But the kind ...

It doesn’t make ... of mycosis fungoides or Sézary syndrome; — Oxlumo, for the treatment of hyperoxaluria type 1; — Epkinly, for relapsed or refractory diffuse large B-cell lymphoma ...

HALIFAX - Nova Scotia still hasn’t signed on to the federal government’s pharmacare plan, and the province’s Opposition New Democrats are wondering why. NDP Leader Claudia Chender said ...